Scarica l'app Stockscreener
589.74
0.38%
1.719
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$588.02
Aprire:
$586.1
Volume 24 ore:
1.49M
Relative Volume:
0.74
Capitalizzazione di mercato:
$222.69B
Reddito:
$43.74B
Utile/perdita netta:
$6.58B
Rapporto P/E:
34.07
EPS:
17.3072
Flusso di cassa netto:
$6.11B
1 W Prestazione:
+4.29%
1M Prestazione:
+12.52%
6M Prestazione:
+37.60%
1 anno Prestazione:
+8.92%
Intervallo 1D:
$578.25
$598.51
Intervallo di 1 settimana:
$563.30
$598.51
Portata 52W:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
589.74 | 220.92B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
223.01 | 154.97B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
700.90 | 56.98B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.65 | 42.96B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.82 | 37.62B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Are Wall Street Analysts Predicting Thermo Fisher Scientific Stock Will Climb or Sink? - Barchart.com
Cell Expansion Market Size to Hit USD 77.08 Billion by 2034 - GlobeNewswire Inc.
How robust is Thermo Fisher Scientific Inc stock financial positionPortfolio Performance Report & AI Based Trade Execution Alerts - newser.com
Will Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock hit analyst forecastsSell Signal & Long-Term Safe Investment Ideas - newser.com
Finalists in the Thermo Fisher JIC explore biomimicry with SERC - societyforscience.org
Thermo Fisher Scientific Receives 510(K) Clearance in the United States for EXENT System to Aid in the Diagnosis of Multiple Myeloma - MarketScreener
Thermo Fisher Scientific Says US FDA Clears Exent System for Multiple Myeloma Diagnosis - MarketScreener
Thermo Fisher’s new diagnostic system for multiple myeloma gets FDA clearance - Investing.com India
Thermo Fisher (NYSE: TMO) receives FDA 510(k) for EXENT M-protein detection for myeloma - Stock Titan
Why analysts remain bullish on Thermo Fisher Scientific Inc. stock2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Should Thermo Fisher's (TMO) New $5 Billion Buyback Change Views on Its Capital Allocation Priorities? - simplywall.st
Is Thermo Fisher Scientific Inc stock in buy zone after pullback2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
Why Thermo Fisher Scientific Inc. stock is rated strong buyJuly 2025 Opening Moves & Expert Verified Stock Movement Alerts - newser.com
Thermo Fisher (TMO) sr. VP Britt sells $5.8 million in stock - Investing.com India
Thermo Fisher Scientific Insider Sold Shares Worth $5,844,850, According to a Recent SEC Filing - MarketScreener
Implied Volatility Surging for Thermo Fisher Stock Options - Yahoo Finance
Will Thermo Fisher Scientific Inc stock outperform benchmarks2025 Stock Rankings & Daily Market Momentum Tracking - newser.com
Thermo Fisher Scientific Inc. recovery potential after sell offWeekly Profit Report & Daily Volume Surge Trade Alerts - newser.com
Gene Expression Market Forecast 2025-2032: Emerging Trends, - openPR.com
Is Thermo Fisher Scientific Inc. (TN8) stock among top earnings plays2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years - Sahm
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement - simplywall.st
Thermo Fisher (TMO) Announces $5 Billion Share Buyback Plan - GuruFocus
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact - GuruFocus
Published on: 2025-11-07 08:49:17 - newser.com
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock gains from tech spendingBear Alert & Daily Entry Point Trade Alerts - newser.com
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Stock Is Going Strong: Have Financials A Role To Play? - Yahoo Finance
Thermo Fisher Scientific authorizes share repurchases - Medical Buyer
United States Softgels Capsules Market Analysis 2025 | Industry - openPR.com
Building Trusted CDMO Relationships: A CPHI Conversation with Thermo Fisher Scientific, Part Two - PharmTech.com
Thermo Fisher Scientific declares $0.43 quarterly dividend By Investing.com - Investing.com Nigeria
Thermo Fisher Scientific introduces the Helios MX1 PFIB-SEM - SelectScience
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases - BioSpace
Thermo Fisher Scientific Declares Quarterly Dividend payable on January 15, 2026 - BioSpace
Thermo Fisher Scientific (TMO) Announces $5B Share Buyback - GuruFocus
Thermo Fisher Scientific authorizes $5 billion of share repurchases - MarketScreener
Thermo Fisher authorizes $5B in share buybacks - MSN
Thermo Fisher Scientific Plans $5 Billion Share Repurchase Program, Maintains Quarterly Dividend - MarketScreener
Thermo Fisher announces $5 billion share repurchase program By Investing.com - Investing.com South Africa
Thermo Fisher Scientific declares $0.43 quarterly dividend - Investing.com
Thermo Fisher announces $5 billion share repurchase program - Investing.com India
Thermo Fisher Scientific Reinforces Investor Confidence with Latest Quarterly Dividend Declaration - Markets Financial Content
Thermo Fisher Scientific Declares Quarterly Dividend - The Joplin Globe
Diamond Hill Capital Large Cap Fund Added Thermo Fisher Scientific (TMO) on a Dip - Insider Monkey
Why Thermo Fisher Scientific Stock Jumped 40%? - Trefis
Is Thermo Fisher Scientific Inc. (TN8) stock supported by strong fundamentalsMarket Movers & Consistent Growth Equity Picks - newser.com
What makes Thermo Fisher Scientific Inc. (TN8) stock appealing to growth investors - newser.com
Array Market (Life Science and Biotechnology Instruments) - openPR.com
Is Thermo Fisher Scientific Inc. stock a top pick in earnings seasonJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
How Thermo Fisher Scientific Inc. stock valuations compare to rivalsQuarterly Portfolio Report & Technical Pattern Based Signals - fcp.pa.gov.br
Published on: 2025-11-06 01:31:20 - newser.com
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.62%
0.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):